ArticleJournal of immunology (Baltimore, Md. : 1950)2022

Akt-2 Is a Potential Therapeutic Target for Disseminated Candidiasis.

Ling Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.